Synthesis and Characterization of Mesoporous Silica MCM-41 and its use as Potential Drug Carrier

Authors

  • Muhammad Asif Riphah International University Islamabad. Author
  • Umar Farooq Riphah International University Islamabad Author
  • Shamshad Ahmad Government College University Faisalabad Author
  • Husnain Haider Chemistry department COMSATS University Islamabad, Lahore Campus Author
  • Saeed Ahmad Chemistry Department University of Lahore. Author

Keywords:

Mesoporous Silica, Potential Drug Carrier, Scanning Electron Microscopy

Abstract

In developing countries to control viral and microbial infections, it is one of the biggest challenges to develop a resistance against antiviral and anti-microbial. This study was aimed at drug-loaded mesoporous silica nanoparticles (MSN)” with ciprofloxacin and daclatasvir. Drug- loaded mesoporous silica nanoparticles were prepared & studied their releasing properties. The prepared materials were characterized by “Fourier- transform infrared spectroscopy” (FTIR), “nitrogen adsorption/desorption analysis, and “scanning electron microscopy”” (SEM). Nanoparticles were loaded with drugs ciprofloxacin and daclatasvir for 24 hours which shows percent loading as 38.7% and 45.5% respectively. The results show that separate and distinct profiles were observed for both drugs. The MCM-41 loaded with Daclatasvir shows a faster rate of drug release compared to MCM-41 loaded with Ciprofloxacin. The finding suggests that MCM -41 could be a potential drug carrier system for controlled and extended release of antiviral and microbial drugs to enhance the drug efficiency to heal and treat infectious diseases. The release profile of both drugs was studied for 24 hours in vitro drug release.

References

1. Thommes, M., et al., Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report). 2015. 87(9-10): p. 1051-1069.

2. Barbe, C., et al., Silica particles: a novel drug‐delivery system. 2004. 16(21): p. 1959-1966.

3. Singh, R., J.W.J.E. Lillard Jr, and m. pathology, Nanoparticle-based targeted drug delivery. 2009. 86(3): p. 215-223.

4. Tang, F., L. Li, and D.J.A.m. Chen, Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. 2012. 24(12): p. 1504-1534.

5. Unger, K., et al., The use of porous and surface modified silicas as drug delivery and stabilizing agents. 1983. 9(1-2): p. 69-91.

6. Li, Z., et al., Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery. 2010. 342(2): p. 607-613.

7. Cauda, V., et al., Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly (ethylene glycol). 2010. 132(1-2): p. 60-71.

8. Derrien, A., G. Renard, and D. Brunei, Guanidine linked to miceile-templated mesoporous silicates as base catalyst for transesterification, in Studies in Surface Science and Catalysis. 1998, Elsevier. p. 445-452.

9. Liu, D., et al., The smart drug delivery system and its clinical potential. 2016. 6(9): p. 1306.

10. Uglea, C.V., et al., Drug delivery systems based on inorganic materials: I. Synthesis and characterization of a zeolite-cyclophosphamide system. 1995. 6(7): p. 633-637.

11. Mokaya, R., W. Zhou, and W.J.C.C. Jones, A method for the synthesis of high quality large crystal MCM-41. 1999(1): p. 51-52.

12. Ciesla, U., F.J.M. Schüth, and m. materials, Ordered mesoporous materials. 1999. 27(2-3): p. 131-149.

13. Zeng, W., et al., The drug delivery system of MCM-41 materials via co-condensation synthesis. 2006. 97(2-3): p. 437-441.

14. Ferrari, M.J.N.r.c., Cancer nanotechnology: opportunities and challenges. 2005. 5(3): p. 161-171.

15. Charnay, C., et al., Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. 2004. 57(3): p. 533-540.

16. Kortesuo, P., et al., In vitro evaluation of sol–gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. 2000. 200(2): p. 223-229.

17. Schwanke, A.J., R. Balzer, and S.J.H.o.e. Pergher, Microporous and mesoporous materials from natural and inexpensive sources. 2017: p. 1-22.

18. Lai, C.-Y., et al., A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. 2003. 125(15): p. 4451-4459.

19. Illangakoon, U.E., et al., 5-Fluorouracil loaded Eudragit fibers prepared by electrospinning. 2015. 495(2): p. 895-902.

20. Zhao, X.S., et al., Synthesis and characterization of highly ordered MCM-41 in an alkali-free system and its catalytic activity. 1996. 38: p. 33-37.

21. Barrett, E.P., L.G. Joyner, and P.P.J.J.o.t.A.C.s. Halenda, The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. 1951. 73(1): p. 373-380.

22. Alonso, M.J.J.B. and Pharmacotherapy, Nanomedicines for overcoming biological barriers. 2004. 58(3): p. 168-172.

23. Hao, X., et al., Hybrid mesoporous silica-based drug carrier nanostructures with improved degradability by hydroxyapatite. 2015. 9(10): p. 9614-9625.

24. Wang, C., et al., Synergic Deoxy Reforming of Cellulose and Fatty Oil Using Molecular‐Sieve‐Supported Molybdenum Carbide and Tungsten Carbide towards Hydrocarbon‐Rich Oil for Fuels. 2017. 5(12): p. 2216-2225.

25. Chen, J., et al., Distinguishing the Silanol Groups in the Mesoporous Molecular Sieve MCM‐41. 1996. 34(23‐24): p. 2694-2696.

26. Doadrio, A., et al., Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. 2004. 97(1): p. 125-132.

27. Swapna, N.J. and G.J.I.j.o.p. Nadkarni, Effect of size and charge of liposomes on biodistribution of encapsuled ggmTc-DTPA in rats. 1998. 30(3): p. 199.

28. Arifin, D.Y., L.Y. Lee, and C.-H.J.A.d.d.r. Wang, Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. 2006. 58(12-13): p. 1274-1325.

29. Fu, Y. and W.J. Kao, Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert opinion on drug delivery, 2010. 7(4): p. 429-444.

30. Arifin, D.Y., L.Y. Lee, and C.-H. Wang, Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Advanced drug delivery reviews, 2006. 58(12-13): p. 1274-1325.

31. Andersson, J., et al., Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro-and mesoporous silica matrices. 2004. 16(21): p. 4160-4167.

Downloads

Published

2024-03-31

How to Cite

Synthesis and Characterization of Mesoporous Silica MCM-41 and its use as Potential Drug Carrier. (2024). International Research Journal of Management and Social Sciences, 5(1), 735-746. https://irjmss.com/index.php/irjmss/article/view/325

Similar Articles

1-10 of 41

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)